Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

"IRX Therapeutics, Inc. - Product Pipeline Review - 2012" Published


Print article Print article
2013-01-28 06:59:39 - Recently published research from Global Markets Direct, "IRX Therapeutics, Inc. - Product Pipeline Review - 2012", is now available at Fast Market Research

Global Market Direct's pharmaceuticals report, "IRX Therapeutics, Inc. - Product Pipeline Review - 2012" provides data on the IRX Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, IRX Therapeutics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from IRX Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* IRX Therapeutics, Inc. - Brief IRX Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of IRX Therapeutics, Inc.

human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of IRX Therapeutics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the IRX Therapeutics, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/530136_irx_therapeutics_inc_product_pipeline ..


Reasons to buy

* Evaluate IRX Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of IRX Therapeutics, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the IRX Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with IRX Therapeutics, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of IRX Therapeutics, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
IRX Therapeutics, Inc. Snapshot
IRX Therapeutics, Inc. Overview
Key Information
Key Facts
IRX Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
IRX Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
IRX Therapeutics, Inc. - Pipeline Products Glance
IRX Therapeutics, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
IRX Therapeutics, Inc. - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
IRX Therapeutics, Inc. - Drug Profiles
IRX-2
Product Description
Mechanism of Action
R&D Progress
IRX-2 + DepoVax Cancer Vaccine
Product Description
Mechanism of Action
R&D Progress
IRX-3
Product Description
Mechanism of Action
R&D Progress
IRX-4-6
Product Description
Mechanism of Action
R&D Progress
methyl inosine monophosphate
Product Description
Mechanism of Action
R&D Progress
IRX Therapeutics, Inc. - Pipeline Analysis
IRX Therapeutics, Inc. - Pipeline Products by Therapeutic Class
IRX Therapeutics, Inc. - Pipeline Products by Route of Administration
IRX Therapeutics, Inc. - Pipeline Products By Mechanism of Action
IRX Therapeutics, Inc. - Recent Pipeline Updates
IRX Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Financial Deals Landscape
IRX Therapeutics, Inc., Deals Summary
IRX Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
IRX Therapeutics Raises $1.5 Million In Venture Financing
IRX Therapeutics Raises $8 Million In Venture Financing
IRX Therapeutics Secures $2 Million In Venture Financing
IRX Therapeutics Secures $25 Million In Series A Financing
Partnerships
IRX Therapeutics Enters Into Research Collaboration With Pharma Company
ImmunoVaccine Enters Into Agreement With IRX Therapeutics
IRX Therapeutics Enters Into Collaboration Agreement With NCRC
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
IRX Therapeutics, Inc., Key Information
IRX Therapeutics, Inc., Key Facts
IRX Therapeutics, Inc. - Pipeline by Indication, 2012
IRX Therapeutics, Inc. - Pipeline by Stage of Development, 2012
IRX Therapeutics, Inc. - Monotherapy Products in Pipeline, 2012
IRX Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2012
IRX Therapeutics, Inc. - Phase II, 2012
IRX Therapeutics, Inc. - Pre-Clinical, 2012
IRX Therapeutics, Inc. - Pipeline By Therapeutic Class, 2012
IRX Therapeutics, Inc. - Pipeline By Route of Administration, 2012
IRX Therapeutics, Inc. - Pipeline Products By Mechanism of Action, 2012
IRX Therapeutics, Inc. - Recent Pipeline Updates, 2012
IRX Therapeutics, Inc., Deals Summary
IRX Therapeutics Raises $1.5 Million In Venture Financing
IRX Therapeutics Raises $8 Million In Venture Financing
IRX Therapeutics Secures $2 Million In Venture Financing
IRX Therapeutics Secures $25 Million In Series A Financing

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=530136&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com